Related Experiment Video

Updated: May 12, 2026

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting
08:14

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

Published on: September 25, 2012

18.7K

Special Issue: The Evolving Landscape of Single-Cell Genomics in CNS and PNS Oncology

Yosef Ellenbogen1,2,3, Mario L Suva4,5, Itay Tirosh6

  • 1Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

Neuro-Oncology Advances
|March 2, 2026
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Nuclei Isolation from Fresh Frozen Brain Tumors for Single-Nucleus RNA-seq and ATAC-seq
06:22

Nuclei Isolation from Fresh Frozen Brain Tumors for Single-Nucleus RNA-seq and ATAC-seq

Published on: August 25, 2020

13.6K
Author Spotlight: Integrating Organoid Models with Single-Cell and Spatial Transcriptomics Technologies
05:45

Author Spotlight: Integrating Organoid Models with Single-Cell and Spatial Transcriptomics Technologies

Published on: March 29, 2024

3.6K

Related Experiment Videos

Last Updated: May 12, 2026

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting
08:14

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

Published on: September 25, 2012

18.7K
Nuclei Isolation from Fresh Frozen Brain Tumors for Single-Nucleus RNA-seq and ATAC-seq
06:22

Nuclei Isolation from Fresh Frozen Brain Tumors for Single-Nucleus RNA-seq and ATAC-seq

Published on: August 25, 2020

13.6K
Author Spotlight: Integrating Organoid Models with Single-Cell and Spatial Transcriptomics Technologies
05:45

Author Spotlight: Integrating Organoid Models with Single-Cell and Spatial Transcriptomics Technologies

Published on: March 29, 2024

3.6K

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

Articles linked to this work by shared authors, journal, and citation graph.

Spatial analysis reveals the evolving organization of IDH-mutant glioma.

Cancer cell·2026

Spatial analysis of head and neck cancer identifies two ecosystems with distinct modes of epithelial-to-mesenchymal transition.

Nature genetics·2026

Vorasidenib improves response to subsequent chemoradiation in a genetically engineered mouse model of IDH-mutant glioma.

Science translational medicine·2026

Oxidized protein states define metastatic fitness in lung cancer.

bioRxiv : the preprint server for biology·2026

Patient-derived resources for decoding and targeting brain metastases ecosystems.

EMBO molecular medicine·2026

Longitudinal changes in DNA methylation in IDH-mutant glioma fuel disease progression through altered cell state differentiation.

Nature genetics·2026

Single-cell RNA sequencing reveals compartment-specific immune and tumor cell states in a contiguous spinal metastasis.

Neuro-oncology advances·2026

Nuclear export inhibition activates TP53 pathways and is a potent therapeutic strategy in atypical teratoid rhabdoid tumors.

Neuro-oncology advances·2026

A 3D in vitro co-culture model to investigate tumor-endothelial interactions in Neurofibromatosis type 2-associated meningiomas.

Neuro-oncology advances·2026

Mutational signature stratification of recurrent gliomas reveals distinct patterns of genomic traits.

Neuro-oncology advances·2026

[18F]FET PET imaging for early response assessment of bevacizumab in recurrent glioblastoma.

Neuro-oncology advances·2026

A novel approach to reverse Warburg metabolism in patients with recurrent glioblastoma: A phase II pharmacodynamic study of dichloroacetate.

Neuro-oncology advances·2026

Clear Cell Carcinoma With Enteroblast-Like Differentiation Involving Multiple Gynecologic Sites: An Integrated Clinicopathologic, Whole-Exome, and Transcriptomic Analysis.

BioFactors (Oxford, England)·2026

Psychiatric disorders and gynecologic tumors: A 2-sample Mendelian randomization study of 20 exposure-outcome pairs.

Medicine·2026

COSMYC: a Core Outcome Set for MYopia clinical trials with Children and young people.

The British journal of ophthalmology·2026

Beyond HPV Positivity: Sex, Host Biology, and Contextual Heterogeneity in Oropharyngeal Cancer.

Critical reviews in oncology/hematology·2026

Early-onset rectal cancer shows aggressive presentation without age-dependent survival effect.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026

Clinical and epidemiological characteristics of colorectal cancer patients in a hospital-based series from Iran, 2009-2019.

Cancer treatment and research communications·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us